Innoviz Technologies (INVZ – Research Report) received a Hold rating and price target from Cantor Fitzgerald analyst Andres Sheppard ...

Cantor Fitzgerald analyst Charles Duncan initiated coverage with a Buy rating on Marinus (MRNS – Research Report) yesterday and set a ...

Small caps’ outperformance should continue into the year-end, according to Eric Johnston, senior managing director at Cantor ...

Cantor Fitzgerald analyst Deepak Mathivanan raised the firm’s price target on Amazon.com (AMZN) to $240 from $210 and keeps ...

On Thursday, SoundHound AI Inc (SOUN) stock saw a modest uptick, ending the day at $6.63 which represents a slight increase of $0.36 or 5.74% from the prior close of $6.27. The stock opened at $6.56 ...

BigBear.ai tumbled 8% during Wednesday afternoon trading after its third quarter 2024 financial results failed to meet market ...

Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $312 from $200 and keeps an Overweight rating on the shares. MicroStrategy, whose core business is being a business ...

Cantor Equity Partners I, a special purpose acquisition company affiliated with Cantor Fitzgerald, filed for a $200 million initial public offering. Howard Lutnick, chairman and chief executive ...

Cantor Fitzgerald raised the firm’s price target on UnitedHealth to $644 from $591 and keeps an Overweight rating on the shares. The firm walked away from UnitedHealth’s Q3 earnings with the ...

Fintel reports that on November 7, 2024, Cantor Fitzgerald upgraded their outlook for Sarepta Therapeutics (LSE:0L35) from Neutral to Overweight. As of October 22, 2024, the average one-year price ...